CFLT241220C31000
- 0.70
- -0.30-30.00%
Confluent Newsroom
Mizuho Securities Maintains Confluent(CFLT.US) With Buy Rating, Raises Target Price to $35
Confluent Price Target Raised to $35.00/Share From $31.00 by Mizuho
Confluent Price Target Raised to $35.00/Share From $32.00 by Truist Securities
Truist Financial Maintains Confluent(CFLT.US) With Buy Rating, Raises Target Price to $35
Truist Raises Price Target on Confluent to $35 From $32, Maintains Buy Rating
Express News | Form 144 | Confluent(CFLT.US) 10% Stockholder Proposes to Sell 6.29 Million in Common Stocks
Express News | Form 144 | Confluent(CFLT.US) 10% Stockholder Proposes to Sell 6.29 Million in Common Stocks
Confluent Is Maintained at Overweight by JP Morgan
Confluent Analyst Ratings
C3.ai, PagerDuty in Focus as JP Morgan Changes Ratings on Enterprise Software Stocks
J.P. Morgan Maintains Confluent(CFLT.US) With Buy Rating, Raises Target Price to $38
Insider Sale: Director at $CFLT (CFLT) Sells 47,425 Shares
Confluent(CFLT.US) Director Sells US$17.09 Million in Common Stock
Express News | Form 144 | Confluent(CFLT.US) Director Proposes to Sell 3.4 Million in Common Stocks
MongoDB Tumbles Following Q3 Results, CFO Announces Retirement
New Confluent Platform for Apache Flink Makes It Easy to Manage and Secure High-Performance Stream Processing On-Premises
Express News | Form 144 | Confluent(CFLT.US) Director Proposes to Sell 9.83 Million in Common Stocks
Access Physical Therapy & Wellness Expands Footprint With Acquisition of Physical Therapy Associates of Schenectady
MongoDB Climbs as It Appears Likely to Beat Q3 Earnings Estimates: Stifel
Searching for the Top AI Stocks of 2025